Supplementary Table 3.
Screening of positive ANA prepandemıc samples (i.e., prior Covid-19) against different viruses.
Sample | Gender | ANA IgG | Dengue | Chikungunia | HEV IgM | HEV IgG | B19V IgM | B19V IgG | WNV IgM | WNV IgG |
---|---|---|---|---|---|---|---|---|---|---|
A | M | positive | positive | Negative | ND | ND | Negative | Positive | Negative | Positive |
B | M | positive | Negative | Negative | Negative | Negative | Negative | Positive | Negative | Negative |
C | M | positive | ND | ND | Negative | Negative | Negative | Positive | ND | ND |
D | M | positive | ND | ND | ND | ND | Negative | Positive | ND | ND |
E | M | positive | ND | ND | ND | ND | ND | ND | Negative | Positive |
ND: Not determined.